AdaptHealth Corp. to Participate in Upcoming Investor Conference
CONSHOHOCKEN, Pa.--(BUSINESS WIRE)--AdaptHealth Corp. (NASDAQ: AHCO) (“AdaptHealth” or the “Company”), a national leader in providing more...
Nuvation Bio to Participate in Upcoming Investor Conferences
NEW YORK--(BUSINESS WIRE)--Nuvation Bio Inc. (NYSE: NUVB), a global oncology company focused on tackling some more...
Vicarious Surgical to Report Third Quarter 2025 Financial Results on November 13, 2025
WALTHAM, Mass.--(BUSINESS WIRE)--Vicarious Surgical Inc. (“Vicarious Surgical” or the “Company”) (NYSE: RBOT, RBOT WS), a more...
Beyond Detection: How RapidAI is Redefining Clinical AI with Problem-Solving at Scale
At HLTH 2025 in Las Vegas, conversations about artificial intelligence in medical imaging often more...
Insulet Champions Workplace Inclusion for People with Diabetes with New Data and Tools Released for Diabetes Awareness Month
Insulet launches campaign inspired by the International Diabetes Federation’s focus on diabetes, well-being, and the more...
Surmodics Announces Results from Sex-Specific Analysis of the PROWL Registry Study of Real-World Limb Ischemia Patients Treated with the Pounce™ Thrombectomy Platform
Analysis of 160 patients with acute, subacute, or chronic symptoms of thrombotic limb ischemia receiving more...
Owlet to Report Third Quarter 2025 Financial Results on November 13, 2025
LEHI, Utah--(BUSINESS WIRE)--$owlt #babymonitor--Owlet, Inc. (“Owlet” or the “Company”) (NYSE: OWLT), the pioneer of smart more...
Align Technology Announces New Innovations for iTero™ Digital Solutions, a Comprehensive Ecosystem That Includes Intraoral Scanners and Integrated Software Tools That Enhance the Chairside Patient Experience
Series of new features enable patients to see their comprehensive oral health condition and potential more...
Phibro Animal Health Corporation to Host Webcast and Conference Call on First Quarter Results
TEANECK, N.J.--(BUSINESS WIRE)--Phibro Animal Health Corporation (Nasdaq: PAHC) expects to announce its first quarter financial more...
FDA Grants Interchangeable Designation to Fresenius Kabi’s Biosimilars Conexxence® and Bomyntra® (denosumab-bnht)
LAKE ZURICH, Ill.--(BUSINESS WIRE)--#CommittedToLife--Fresenius Kabi, part of the global healthcare company Fresenius, and a leading more...